Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, discussed how the standard of care for melanoma is evolving.
Karen Knudsen
Advertisement
Articles by Karen Knudsen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
4
If I Have Cancer Again
5